Unit: Payer Research & Market Access Consulting
Indication: Congestive heart failure (CHF)
Subject: European market access policies for a new product
Target group: Representatives of European assessment bodies (G-BA, HAS, NICE)
Method: Individual telephone interviews, analysis, top line report
Sample: N = 6
Year: 2014